The Lancet: January 27, 2012

Discussion of a molecular assay that could identify patients at risk of disease recurrence after resection of stage I lung cancer.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv